Monoclonal antibodies are biologic drugs that are used to treat certain types of diseases such as arthritis, neurological diseases, heart diseases, inflammatory diseases, and many more. Since their introduction, the applications of monoclonal antibodies have expanded significantly. Monoclonal antibodies are now being developed for various neurological disease such as Alzheimer’s, multiple sclerosis, etc.  Currently approved monoclonal antibodies for neurological conditions include natalizumab, ocrelizumab, alemtuzumab, and many more. Rise in the burden of neurological diseases with high clinical unmet needs, strong clinical pipeline of neuronal monoclonal antibodies, and rise in awareness are factors that are driving the global neuronal monoclonal antibodies market. It is estimated that Alzheimer’s disease and other dementias affect 47 million people worldwide, and the number is expected to increase threefold by 2050. However, disappointing results of promising pipeline molecule and high cost of therapy are anticipated to restrain the growth of the global neuronal monoclonal antibodies market. Moreover, a stringent regulatory scenario is likely to hamper the growth of the global neuronal monoclonal antibodies market during forecast period. 

The global neuronal monoclonal antibodies market can be segmented based on drug class, application, distribution channel, and region. In terms of drug class, the global neuronal monoclonal antibodies market can be classified into amyloid inhibitors, tau protein inhibitors, alpha-synuclein inhibitors, integrin antagonists, and others. Based on application, the global neuronal monoclonal antibodies market can be segmented into multiple sclerosis, Parkinson’s disease, Alzheimer's disease, amyotrophic lateral sclerosis, and others. The multiple sclerosis segment is expected to hold a significant share of the market due to approval of monoclonal antibodies. In terms of distribution channel, the market can be classified into hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacies segment is expected to expand at a significant CAGR during forecast period, owing to an increase in the number of Internet users, availability of medicines at a low cost online compared to hospital and retail pharmacies, and ease of useof the online platform. 

Based on geography, the global neuronal monoclonal antibodies market can be classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Currently, North America dominates the global neuronal monoclonal antibodies market and is closely followed by Europe. High prevalence of neurological diseases, availability of highly advanced health care facilities, strong clinical pipeline of neuronal monoclonal antibodies, higher health care spending, and availability of reimbursement policies are some of the factors boosting the neuronal monoclonal antibodies market in North American and Europe. The market in Asia Pacific is expected to exhibit a significant potential in the near future. Factors such as rapidly developing health care infrastructure, rise in disposable income, increase in the burden of Alzheimer's disease and other dementias, increasing healthcare spending, and government initiatives in the countries of Asia Pacific are some of the factors that are expected to fuel the growth of the neuronal monoclonal antibodies in Asia Pacific. India, China, and Japan are expected to exhibit significantly higher growth potential in the neuronal monoclonal antibodies market in Asia Pacific, owing to a large population base with high clinical unmet needs. The neuronal monoclonal antibodies market Middle East & Africa is estimated to expand at a steady rate during forecast period, owing to poorly developed health care facilities in the region. 

Major players operating in global neuronal monoclonal antibodies market are GlaxoSmithKline, Sanofi S. A., Biogen, Eli Lilly & Co. Bristol-Myers Squibb, and many more.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.       

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Neuronal Monoclonal Antibodies Market

Pre Book